Dysthymia
Pharmacotherapy of dysthymia is affected by routine use of operational diagnostic criteria
Published in Medical Letter on the CDC and FDA, September 17th, 2006
According to a report from Japan, "The purpose of the present paper was to evaluate, with the use of a questionnaire, how Japanese psychiatrists diagnose and treat a typical adult dysthymia case."
"Clinicians who routinely use operational diagnostic criteria (ODC) had more correct diagnoses than those who did not," said Taro Endo and colleagues at Niigata University. "Approximately 70% of psychiatrists who routinely use ODC chose selective serotonin re-uptake inhibitors (SSRI) as the first choice of treatment, while of those psychiatrists who do not use these...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diarrhea Epidemiology
Bacterial diarrhea and antimicrobial resistance in western Kenya were examined - Drug Safety
U.S. FDA warns three pharmacies to stop mass-producing unapproved inhalation drugs - Environmental Health
Mycobacterium enzymes degrade polycyclic aromatic hydrocarbons - Food Safety
Salmonella contamination of eggs is national epidemic in U.S. - Accreditation
Humana Military Healthcare Services receives URAC accreditation - Addiction Medicine
Effectiveness of detoxification programs at detention centers in Taiwan is in question - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
